ATHEROSCLEROSIS
African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study
Tulika Jain, MD*,
Ronald Peshock, MD*,
Darren K. McGuire, MD, MHSc*,
DuWayne Willett, MD*,
Zhoazia Yu, MS ,
Gloria L. Vega, PhD*,
Rudy Guerra, PhD,
Helen H. Hobbs, MD*, ,
Scott M. Grundy, MD, PhD*,* the Dallas Heart Study Investigators
* Donald W. Reynolds Cardiovascular Clinical Research Center and the Department of Internal Medicine, Dallas, TexasUSA
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TexasUSA
Department of Statistics, Rice University, Houston, TexasUSA
Manuscript received January 21, 2004;
revised manuscript received April 20, 2004,
accepted May 19, 2004.
* Reprint requests and correspondence: Dr. Scott M. Grundy, Center for Human Nutrition, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Room Y3206, Dallas, Texas 75390-9052 (Email: scott.grundy{at}utsouthwestern.edu).
 |
Abstract
|
|---|
OBJECTIVES: We sought to compare the prevalence of coronary atherosclerosis in a cohort of middle-age African American (black) and non-Hispanic Caucasian (white) men and women from a population-based probability sample.
BACKGROUND: Blacks have a higher mortality from coronary heart disease (CHD) than whites, particularly among younger individuals, and yet several studies have reported that coronary atherosclerosis is less prevalent in blacks than in whites. Data from population-based samples comparing coronary atherosclerotic burden between blacks and whites are limited.
METHODS: The prevalence of coronary atherosclerosis in middle-aged blacks and whites was determined using coronary calcium measured by electron beam computed tomography in 1,289 men and women from a population-based probability sample from Dallas, Texas.
RESULTS: The population estimates of the frequency of a positive scan for coronary artery calcium were not statistically different between black and white men (37% vs. 41%, p = 0.36) or between black and white women (29% vs. 23%, p = 0.21). Although the prevalence of most of the coronary risk factors varied significantly between blacks and whites, mean Framingham coronary risk factor scores were identical in black and white men (10 ± 4) but significantly higher in black women (13 ± 4) than in white women (12 ± 4).
CONCLUSIONS: Blacks in the general population have a prevalence of coronary atherosclerosis similar to whites. Factors other than coronary atherosclerotic burden, which are not reflected in the Framingham risk score, contribute significantly to the higher CHD mortality rate in blacks.
|
Abbreviations and Acronyms
| | BMI = body mass index | | BP = blood pressure | | CAC = coronary artery calcium | | CARDIA = Coronary Artery Risk Development In young Adults study | | CHD = coronary heart disease | | DHS = Dallas Heart Study | | EBCT = electron beam computed tomography | | HDL = high-density lipoprotein | | LDL = low-density lipoprotein | | NCEP = National Cholesterol Education Program |
|
Mortality from coronary heart disease (CHD) is higher in African Americans (blacks) than in non-Hispanic Caucasians (whites), especially among women (1–3). The higher prevalence of hypertension, left ventricular hypertrophy, diabetes, and chronic renal failure (4,5), as well as a reduced access to medical care (3,6,7), are likely contributors to the higher rate of CHD mortality in blacks. It remains controversial whether blacks have a greater coronary atherosclerotic burden than whites. In post-mortem and angiographic studies, blacks have been reported to have less or equivalent amounts of coronary atherosclerosis when compared with whites (8,9–13).
Coronary atherosclerosis can be assessed noninvasively by measuring the amount of coronary artery calcium (CAC), either by fluoroscopy or by electron beam computed tomography (EBCT). Coronary calcium measurements are proportional to coronary atherosclerotic burden (14–17). In several previous studies, the prevalence of CAC in blacks was found to be significantly lower than in whites (18–21). The exceptions are two studies that reported a similar prevalence of EBCT-detected coronary calcium in blacks and whites—one in young adults (22) and the other in postmenopausal women (23).
In this study, we used EBCT to compare the prevalence of coronary atherosclerosis in middle-aged blacks and whites in a population-based sample using EBCT. We also examined the relationship of coronary atherosclerotic burden to individual cardiovascular risk factors and to the Framingham risk factor scores in the two ethnic groups.
|
Methods
|
|---|
Study population.
The Dallas Heart Study (DHS) is a multiethnic, probability-based sample of the Dallas county population in which blacks were systematically over-sampled so the final sample was 50% black (24). Data from the study participants in the DHS were collected in three stages. First, structured interviews and anthropometric and blood pressure (BP) measurements were performed in the homes of 6,101 individuals age 18 to 65 (54% black). A second home visit was performed on a subset of 3,398 participants, age 30 to 65 (52% black), to obtain blood and urine. Of these, 2,971 underwent EBCT and other imaging measures (24). The prevalence of CAC positive (CAC+) scans by criteria described in this report was very low in men age <40 (black men 8%; white men 2%) and women age <45 (black women 3%; white women 5%); the 940 subjects in this age range were excluded from the analysis. Hispanics and individuals of other ethnicity were also excluded from the analysis (n = 577). The final sample included 528 whites (242 women, 286 men) and 761 blacks (380 women and 381 men). Black and white DHS participants not included in the dataset included those individuals who exceeded the weight limit of the table (36 black and 5 white women; 30 black and 14 white men), had poor quality scans due to breathing or movement artifacts (38 black and 2 white women; 13 black and 1 white men), had a previous surgical procedures (3 black and 2 white women; 10 black and 5 white men), suffered from claustrophobia (n = 2) or fear of radiation (n = 1), refused the study, or (n = 1) in which the equipment failure and the study could not be rescheduled (n = 5).
EBCT protocol and CAC classification.
Electron beam computed tomography image acquisition was gated to the electrocardiogram at 80% of the RR interval using an Imatron C-150XP EBCT scanner (Imatron Inc., San Bruno, California), 30 cm FOV, 512 matrix, sharp reconstruction kernel and a 3-mm slice with a table increment of 3 mms. Beginning at the level of the carina, sufficient slices were acquired (n =  40) to span the heart during a single inspiratory breath-hold. Duplicate scans were performed within 1 to 2 min while the subject remained supine. The data was then analyzed in a separate workstation (NeoImagery Industries, City of Industry, California). A focus was defined as a region of three or more contiguous voxels with a computed tomography (CT) number >130 HU. The voxel size was 0.586 x 0.586 x 3 mm (field of view 30 cm, matrix 512, 3-mm slice) so that 3 voxels would be a volume of 3.08 mm. Scans were read blinded by a single individual, and only foci within the coronary arteries were scored. Results were expressed in Agatston U (25,26), and the mean of the two scores was used as the final CAC score. Individuals with a mean EBCT score >10 Agatston U were classified as CAC+.
Risk factor measurements.
Height, weight, BP, plasma lipids, and glucose were measured, and the body mass index (BMI) was calculated using standard methods (24). Smoking was defined as cigarette use within the previous 30 days and a lifetime history of having smoked  100 cigarettes. Thresholds for categorical variables were defined according to National Cholesterol Education Program (NCEP) (27,28): high total cholesterol 240 mg/dl; high low-density lipoprotein (LDL) cholesterol 160 mg/dl, and high triglycerides 150 mg/dl. Low high-density lipoprotein cholesterols were defined according to the NCEP cut-points for metabolic syndrome (27,28) (<40 mg/dl for men and <50 mg/dl for women). Obesity (29) was defined as a BMI 30 kg/m2, and diabetes was defined as a fasting serum glucose 126 mg/dl, self-reported diabetes, or taking hypoglycemic medication. Elevated systolic and diastolic BPs were defined as 140 mm Hg and 90 mm Hg, respectively, and hypertension was defined as BP 140/90 mm Hg or taking antihypertensive medication(s). Framingham risk scores for men and women were determined from major risk factors according to the algorithm presented in NCEP guidelines (27,28).
Statistical analysis.
The DHS is a probability-based sample of Dallas county that was designed to include 50% blacks in the final clinic visit (visit 3), which was the source of the data for this study. To obtain unbiased estimates of population parameters, and to accommodate sampling biases, such as varying participation rates across sampling strata, sampling weights were applied to the data (24) using the survey (svy) package (Stata Corp., College Station, Texas). Statistical analyses were performed with and without sample weights using statistical packages S-Plus (Insightful, Seattle, Washington) and Stata. The unweighted results are presented because they are based on actual observed data and do not depend on additional assumptions associated with statistical analysis of complex probability surveys (30). The weighted data are presented only if the results differ significantly from the unweighted results.
Continuous demographic and clinical characteristics are presented as means and SD, and categorical variables are reported as relative frequencies. Student t test or analysis of variance was used to compare means of continuous variables, and associations between categorical variables were evaluated using a chi-square test. Coronary calcium scores were analyzed both as a continuous and a binary (above/below 10 Agatston U) variable. Logistic regression models were used to evaluate the association between CAC prevalence (as a binary dependent variable) and clinical characteristics, including cardiovascular risk factors. Because CAC prevalence increases with age, all logistic regression analyses included age as a covariate. These methods were used to analyze the entire dataset, as well as stratified analyses defined by ethnicity and gender. In logistic models based on the entire dataset, we included ethnicity and gender as covariates. Logistic model diagnostics were summarized by the area under receiver operator characteristic curves; areas above 70% indicate good model discrimination between CAC+ and CAC– subjects (31). All statistical testing was assessed at a 5% significance level, and mean comparisons were two-tailed.
|
Results
|
|---|
Characteristics of the study population.
Baseline characteristics according to ethnicity and gender are presented in Table 1. The age distributions between black and white women were similar, as were the distributions between black and white men.Mean BMI was higher in black women than in white women, but was similar in black and white men. Mean systolic BP, diastolic BPs, and plasma glucose levels were significantly higher in both black men and black women than their white counterparts. Compared with white men, black men had lower plasma levels of cholesterol, triglyceride, and LDL cholesterol, and higher plasma levels of high-density lipoprotein cholesterol; however, none of these lipid variables was significantly different between black and white women. Despite these differences in prevalence of cardiovascular risk factors, the mean Framingham coronary risk factor scores (27,28), which predict the absolute 10-year probability of having a coronary event, were identical in black and white men. In contrast with men, the mean Framingham scores were significantly higher in black women than in white women.
Significant differences in the prevalence of discrete cardiovascular risk factors in blacks and whites were also found. Smoking rates were significantly higher in black men than in white men. Hypertension, elevated BP at entry, and diabetes were significantly more common in blacks. Compared with white men, a greater proportion of black men had a high plasma level of total cholesterol (240 mg/dl), but significantly fewer black men had a low plasma level of high-density lipoprotein cholesterol (<40 mg/dl); no ethnic differences were observed in the frequency of elevated plasma levels of LDL cholesterol (160 mg/dl). For both genders, high plasma levels of triglycerides (150 mg/dl) were less common in blacks. Black women were more frequently obese (BMI 30 kg/m2) than whites, but obesity rates were not significantly different between black and white men.
Determining a threshold for positive coronary calcium..
Electron beam computed tomography measurements of CAC are complicated by X-ray scattering due to obesity and interference from adjacent tissues (32). To reduce the false-positive rate of CAC classification, duplicate scans were performed (Fig. 1A) and evaluated for reproducibility. Concordance of CAC scores (i.e., both scores being above or below a given threshold) was assessed (Fig. 1B). Due to high interscan variability in CAC scores within the range of 0 to 10, CAC+ status was defined as mean score >10 Agatston U; at 10 Agatston U, more than 95% of subjects were concordant for positive (>10) or negative ( 10) scores in the replicate EBCT scans (Fig. 1). Raising the threshold to 15 or 20 Agatston U only modestly increased the concordance between the two scans. Therefore, >10 Agatston U was chosen as a threshold to define a CAC+ status.
View larger version (29K):
[in this window]
[in a new window]
|
Figure 1 (A) The relationship between coronary artery calcium (CAC) scores from duplicate electron beam computed tomography scans. No subjects with a CAC score >10 Agatston U had a second CAC score = 0 Agatston U. (B) Concordance of calcium classification (i.e., both scores being above or below a given threshold CAC score) for subjects in different body mass index (BMI) categories.
|
|
Comparison of coronary calcium prevalence rates among study groups.
Coronary artery calcium scores were highly positively skewed (black skewness = 8; white skewness = 11), with median values (50th percentile) being dramatically lower than mean values in all groups (Table 2). In all ethnicity-gender groups, CAC scores increase progressively with age as indicated by the Spearman correlation coefficient: black men, r = 0.42; black women, r = 0.26; white men, r = 0.49; white women, r = 0.24. As expected, median and mean CAC scores were higher in men than in women in both ethnic groups. No significant differences in the CAC scores or the prevalence of CAC+ status were found between blacks and whites. The CAC+ prevalence was not significantly different in men using either the weighted or unweighted data. The prevalence of CAC+ was significantly higher in black women than in white women using the unweighted data (p < 0.01), but when the weighted data was used, no significant differences in CAC+ prevalence were found between the two ethnic groups (BW = 29% and WW = 23%, p = 0.21). Weighting resulted in relatively larger standard errors and subsequently larger p values, as expected. Regardless of methods applied to analyze the data, CAC+ prevalence was at least as great or greater in black women as in white women. If the threshold for a positive score was raised to 20 Agatston U, the fraction of CAC+ individuals in each ethnic subgroup was reduced slightly, but the proportion of blacks and whites that was CAC+ was similar.
Relation of risk factors to CAC status.
Next we examined the relationship between the individual cardiovascular risk factors and the CAC+ status. The odds ratios for having a positive CAC status associated with each risk factor, adjusted for age, gender, and ethnicity are presented in Table 3. Age and male gender were both highly predictive of CAC+. Other significant predictors of CAC+ status were cigarette smoking, systolic BP, diastolic BP, BMI, and the plasma levels of total cholesterol, high-density lipoprotein cholesterol, triglycerides, and glucose. Plasma levels of LDL cholesterol were marginal as a predictor (p < 0.073). Importantly, no difference in odds ratios for CAC+ was observed for blacks and whites after adjusting for age and gender (odds ratio = 1.2, 95% confidence interval, 0.94 to 1.54). A similar result was obtained using a multivariate regression model with all the factors listed in Table 3 (data not shown).
Table 4 summarizes the relationship between continuous (age, BMI, lipids) and discrete (smoking, hypertension, and diabetes) cardiovascular risk factors by CAC status in all subjects, in blacks and in whites. The strongest, most consistent associations were observed for age, smoking, hypertension, and diabetes; other risk factors were less consistently associated with CAC+ status. Additional significant associations with CAC+ status in whites, but not blacks, were BMI, and plasma levels of LDL cholesterol and high-density lipoprotein cholesterol.
Weighting the data allows for extrapolation of the findings to the general population of Dallas County. For all parameters examined in this study, weighting had only minimal effects on the mean values of the quantitative variables and on the prevalence of the dichotomous traits except when indicated. Weighting introduced only small changes in the nominal p values for differences between blacks and whites, but in all cases the same trends were observed in the weighted and unweighted samples.
|
Discussion
|
|---|
This study reports on a large, representative population of middle-aged black and white men and women in which EBCT was used to compare the prevalence of coronary atherosclerosis in whites and blacks. No significant differences were found in the prevalence of coronary calcium between the two ethnic groups.
Our results differ from most previous studies comparing the prevalence of coronary calcium in blacks and whites, which have reported a higher prevalence of CAC in whites than in blacks (19–21,33,34). For example, Tang et al. (33) used digital subtraction fluoroscopy and conventional cinefluoroscopy to detect coronary calcium in 1,461 asymptomatic high-risk adults and found that blacks had a significantly lower prevalence of coronary calcium than did whites or Asians. Doherty et al. (34) found a lower prevalence of coronary calcium in blacks than whites in 283 high-risk subjects. In 2002, Budoff et al. (11) reported that whites have a greater coronary atherosclerotic burden than blacks or Hispanics, whether atherosclerosis severity was assessed by EBCT or by coronary angiography. In a study of 999 low-risk military personnel (age 40 to 45 years), blacks were found to have a significantly lower prevalence of CAC than whites (21). Another study of older subjects (age 67 to 99 years) also found less coronary calcium in blacks than in whites (19,20).
Only two previous studies using EBCT to assess coronary atherosclerosis reported a similar prevalence of coronary calcium in blacks and whites. The prevalence of EBCT coronary calcification was not significantly different in 443 black and white young adults (age 28 to 40) (22) in the Coronary Artery Risk Development In young Adults (CARDIA) study, although there was a trend toward black women having a higher prevalence of CAC+ status than white women. In the CARDIA study, coronary calcium positive status was defined as having at least one focus of calcium 2.05 mm2 in area; the prevalence of CAC+ was relatively low in this study (16.1% in black men, 17.1% in white men, 11.8% in black women, and 4.6% in white women) due to the young age of the subjects. In a more recent smaller study of 128 black and 733 white asymptomatic postmenopausal women (mean age, 63 ± 8 years), a similar distribution of CAC scores was found between the two ethnic groups. Our study differs from these two studies by being larger, having a broader age range of the subjects, including both genders, and, most importantly, being population-based.
Although black and white men had similar mean Framingham scores, significant ethnic and gender-specific differences were found in the prevalence of the individual cardiovascular risk factors. The prevalence rates of both hypertension and diabetes were higher in blacks than whites, irrespective of gender. Smoking prevalence was higher in black men than in white men. Black women, but not black men, were more obese than their white counterparts. Except for a lower prevalence of elevated plasma triglyceride levels and low plasma high-density lipoprotein cholesterol levels in black men, lipid levels were not significantly different between the two ethnic groups. Thus, blacks (and especially black men) tended to have a more advantageous lipid risk factor profile (i.e., lower triglycerides, higher high-density lipoprotein cholesterol) than whites, but had a significantly higher prevalence of non-lipid risk factors (smoking, diabetes, hypertension), accounting for the similar mean Framingham risk factor scores between the two ethnic groups.
The finding of a similar prevalence of coronary atherosclerosis in blacks and whites in this population-based study of middle-age individuals suggests that the higher rates of coronary heart disease mortality in blacks are not due to an increase in coronary atherosclerotic burden (1–3). The mean Framingham risk scores, which were not significantly different between black and white men, but tended to be higher in black women than white women, correlated with the prevalence of coronary atherosclerosis in this study. But neither the Framingham risk factor scores nor the prevalence of EBCT coronary calcium reflected the significantly higher CHD mortality in blacks than in whites. The Framingham risk factor scores were developed based on coronary events in an almost exclusively white population. When these scores were applied to blacks, they were found to underestimate the impact of hypertension on major coronary events (35) particularly in black women (36). The differences in risk factor profiles in whites and blacks, with blacks having a significantly higher prevalence of non-lipid cardiovascular risk factors (i.e., smoking, diabetes, and hypertension) may be responsible for the overall higher coronary mortality in blacks with coronary atherosclerosis. The greater non-lipid risk factor burden in blacks may predispose to cardiovascular complications. Future studies will be required to determine how ethnic differences in coronary risk factor profiles contribute to the higher coronary mortality associated with coronary atherosclerosis in blacks.
|
Acknowledgments
|
|---|
The authors wish to thank Kevin Vo and Biman Pramanik for assistance in the measurements of the lipids and lipoproteins in this study. The authors also thank Alice Cheng for helpful discussion.
|
Footnotes
|
|---|
Supported by the Donald W. Reynolds Cardiovascular Clinical Research Center at Dallas. Dr. Grundy is supported by the Moss Heart Foundation and a Veterans Affairs Merit grant. Dr. Hobbs is a Howard Hughes Investigator. (A listing of the Dallas Heart Study Investigators is provided in reference 27.)
|
References
|
|---|
1. Manolio TA, Burke GL, Psaty BM, et al. Black-white differences in subclinical cardiovascular disease among older adults: the cardiovascular health study: CHS collaborative research group J Clin Epidemiol 1995;48:1141-1152.[CrossRef][Medline]
2. Liao Y, Cooper RS. Continued adverse trends in coronary heart disease mortality among Blacks, 1980–91 Public Health Rep 1995;110:572-579.[Medline]
3. Williams JE, Massing M, Rosamond WD, et al. Racial disparities in CHD mortality from 1968–1992 in the state economic areas surrounding the ARIC study communities: Atherosclerosis Risk in Communities Ann Epidemiol 1999;9:472-480.[CrossRef][Medline]
4. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S adults. Diabetes Care 1998;21:518-524.
5. Rosenbloom AL, House DV, Winter WE. Non-insulin dependent diabetes mellitus (NIDDM) in minority youth: research priorities and needs Clin Pediatr (Phila) 1998;37:143-152.[Abstract/Free Full Text]
6. Ghali JK, Cooper RS, Kowatly I, et al. Delay between onset of chest pain and arrival to the coronary care unit among minority and disadvantaged patients J Natl Med Assoc 1993;85:180-184.[Medline]
7. Davis SK, Liu Y, Gibbons GH. Disparities in trends of hospitalization for potentially preventable chronic conditions among African Americans during the 1990s: implications and benchmarks Am J Public Health 2003;93:447-455.[Medline]
8. Eggen DA, Solberg LA. Variation of atherosclerosis with age Lab Invest 1968;18:571-579.[Medline]
9. Strong JP, Oalmann MC, Newman WPI, et al. Coronary heart disease in young black and white males in New Orleans: community pathology study Am Heart J 1984;108:747-759.[CrossRef][Medline]
10. Peniston RL, Lu DY, Papademetriou V, et al. Severity of coronary artery disease in black and white male veterans and likelihood of revascularization Am Heart J 2000;139:840-847.[Medline]
11. Budoff MJ, Yang TP, Shavelle RM, et al. Ethnic differences in coronary atherosclerosis J Am Coll Cardiol 2002;39:408-412.[Abstract/Free Full Text]
12. Whittle J, Conigliaro J, Good CB, et al. Black-white differences in severity of coronary artery disease among individuals with acute coronary syndromes J Gen Intern Med 2002;17:867-873.[Medline]
13. Cooper R, Castaner A, Campo A, et al. Severity of coronary artery disease among blacks with acute myocardial infarction Am J Cardiol 1989;63:788-791.[CrossRef][Medline]
14. Rumberger JA, Schwartz RS, Simons DB, et al. Relation of coronary calcium determined by electron beam computed tomography and lumen narrowing determined by autopsy Am J Cardiol 1994;73:1169-1173.[CrossRef][Medline]
15. Rumberger JA, Simons DB, Fitzpatrick LA, et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study Circulation 1995;92:2157-2162.[Abstract/Free Full Text]
16. Budoff MJ, Georgiou D, Brody A, et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: a multicenter study Circulation 1996;93:898-904.[Abstract/Free Full Text]
17. Schmermund AD, Baumgart D, Gorge G, et al. Measuring the effect of risk factors on coronary atherosclerosis: coronary calcium score versus angiographic disease severity J Am Coll Cardiol 1998;31:1267-1273.[Abstract/Free Full Text]
18. Tang JJ, Srivastava RA, Krul ES, et al. In vivo regulation of apolipoprotein A-I gene expression by estradiol and testosterone occurs by different mechanisms in inbred strains of mice J Lipid Res 1991;32:1571-1585.[Abstract]
19. Newman AB, Naydeck BL, Sutton-Tyrrell K, et al. Relationship between coronary artery calcification and other measures of subclinical cardiovascular disease in older adults Arterioscler Thromb Vasc Biol 2002;22:1674-1679.[Abstract/Free Full Text]
20. Newman AB, Naydeck BL, Sutton-Tyrrell K, et al. Coronary artery calcification in older adults to age 99: prevalence and risk factors Circulation 2001;104:2679-2684.[Abstract/Free Full Text]
21. Lee TC, O'Malley PG, Feuerstein I, et al. The prevalence and severity of coronary artery calcification on coronary artery computed tomography in black and white subjects J Am Coll Cardiol 2003;41:39-44.[Abstract/Free Full Text]
22. Bild DE, Folsom AR, Lowe LP, et al. Prevalence and correlates of coronary calcification in black and white young adults: the Coronary Artery Risk Development In young Adults (CARDIA) study Arterioscler Thromb Vasc Biol 2001;21:852-857.[Abstract/Free Full Text]
23. Khurana C, Rosenbaum CG, Howard BV, et al. Coronary artery calcification in black women and white women Am Heart J 2003;145:724-729.[CrossRef][Medline]
24. Victor RG, Haley RW, Willett D, et al. A population-based probability sample for the multidisciplinary study of ethnic disparities in cardiovascular disease: recruitment and validation in the Dallas Heart study. Am J Cardiol 2004;93:1473–80..
25. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography J Am Coll Cardiol 1990;15:827-832.[Abstract]
26. Janowitz WR, Agatston AS, Kaplan G, et al. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women Am J Cardiol 1993;72:247-254.[CrossRef][Medline]
27. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 2002;106:3143-3421.[Free Full Text]
28. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 2001;285:2486-2497.[Free Full Text]
29. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults Arch Intern Med 1998;158:1855-1867.[Free Full Text]
30. Korn EL, Graubard BI. Analysis of Health SurveysNew York, NY: John Wiley & Sons; 1999.
31. Hosmer DW, Lemeshow S. Applied Logistic RegressionNew York, NY: Wiley-Interscience; 2000.
32. Raggi P, Callister TQ, Cooil B. Calcium scoring of the coronary artery by electron beam CT: how to apply an individual attenuation threshold Am J Roentgenol 2002;178:497-502.[Abstract/Free Full Text]
33. Tang W, Detrano RC, Brezden OS, et al. Racial differences in coronary calcium prevalence among high-risk adults Am J Cardiol 1995;75:1088-1091.[CrossRef][Medline]
34. Doherty TM, Tang W, Detrano RC. Racial differences in the significance of coronary calcium in asymptomatic black and white subjects with coronary risk factors J Am Coll Cardiol 1999;34:787-794.[Abstract/Free Full Text]
35. Grundy SM, D'Agostino Sr RB, Mosca L, et al. Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood institute workshop Circulation 2001;104:491-496.[Free Full Text]
36. D'Agostino Sr RB, Grundy S, Sullivan LM, Wilson P, CHD Risk Prediction Group Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation JAMA 2001;286:180-187.[Abstract/Free Full Text]
This article has been cited by other articles:
|
|
|
|
 
A. Rohatgi, P. Patel, S. R. Das, C. R. Ayers, A. Khera, A. Martinez-Rumayor, J. D. Berry, D. K. McGuire, and J. A. de Lemos
Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study
Clin. Chem.,
January 1, 2012;
58(1):
172 - 182.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Grodin, T. M. Powell-Wiley, C. R. Ayers, D. S. Kumar, A. Rohatgi, A. Khera, D. K. McGuire, J. A. de Lemos, and S. R. Das
Circulating levels of matrix metalloproteinase-9 and abdominal aortic pathology: From the Dallas Heart Study
Vascular Medicine,
October 1, 2011;
16(5):
339 - 345.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. B. Nguyen, A. Rohatgi, C. K. Garcia, C. R. Ayers, S. R. Das, S. G. Lakoski, J. D. Berry, A. Khera, D. K. McGuire, and J. A. de Lemos
Interactions Between Smoking, Pulmonary Surfactant Protein B, and Atherosclerosis in the General Population: The Dallas Heart Study
Arterioscler Thromb Vasc Biol,
September 1, 2011;
31(9):
2136 - 2143.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Banks, D. Puttagunta, S. Murphy, M. Lo, D. K. McGuire, J. A. de Lemos, A. Y. Chang, S. M. Grundy, and A. Khera
Clinical Characteristics, Vascular Function, and Inflammation in Women With Angina in the Absence of Coronary Atherosclerosis: The Dallas Heart Study
J. Am. Coll. Cardiol. Img.,
January 1, 2011;
4(1):
65 - 73.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-W. Chiu, S. Adler, M. Budoff, J. Takasu, J. Ashai, and R. Mehrotra
Prevalence and Prognostic Significance of Renal Artery Calcification in Patients with Diabetes and Proteinuria
Clin. J. Am. Soc. Nephrol.,
November 1, 2010;
5(11):
2093 - 2100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Gupta, J. D. Berry, C. R. Ayers, R. M. Peshock, A. Khera, J. A. de Lemos, P. C. Patel, D. W. Markham, and M. H. Drazner
Left Ventricular Hypertrophy, Aortic Wall Thickness, and Lifetime Predicted Risk of Cardiovascular Disease: The Dallas Heart Study
J. Am. Coll. Cardiol. Img.,
June 1, 2010;
3(6):
605 - 613.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. Khouri, R. M. Peshock, C. R. Ayers, J. A. de Lemos, and M. H. Drazner
A 4-Tiered Classification of Left Ventricular Hypertrophy Based on Left Ventricular Geometry: The Dallas Heart Study
Circ Cardiovasc Imaging,
March 1, 2010;
3(2):
164 - 171.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rohatgi, A. W. Owens, A. Khera, C. R. Ayers, K. Banks, S. R. Das, J. D. Berry, D. K. McGuire, and J. A. de Lemos
Differential Associations Between Soluble Cellular Adhesion Molecules and Atherosclerosis in the Dallas Heart Study: A Distinct Role for Soluble Endothelial Cell-Selective Adhesion Molecule
Arterioscler Thromb Vasc Biol,
October 1, 2009;
29(10):
1684 - 1690.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. Lindsey, J. A. de Lemos, F. Cipollone, C. R. Ayers, A. Rohatgi, D. A. Morrow, A. Khera, and D. K. McGuire
Association Between Circulating Soluble Receptor for Advanced Glycation End Products and Atherosclerosis: Observations from the Dallas Heart Study
Diabetes Care,
July 1, 2009;
32(7):
1218 - 1220.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. S. Brilakis, A. Khera, B. Saeed, S. Banerjee, D. K. McGuire, S. A. Murphy, and J. A. de Lemos
Association of Lipoprotein-Associated Phospholipase A2 Mass and Activity with Coronary and Aortic Atherosclerosis: Findings from the Dallas Heart Study
Clin. Chem.,
December 1, 2008;
54(12):
1975 - 1981.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Chen, J. B Lindsey, A. Khera, J. A. D. Lemos, C. R Ayers, A. Goyal, G. L Vega, S. A Murphy, S. M Grundy, and D. K Mcguire
Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study
Diabetes and Vascular Disease Research,
June 1, 2008;
5(2):
96 - 101.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. See, J. B. Lindsey, M. J. Patel, C. R. Ayers, A. Khera, D. K. McGuire, S. M. Grundy, and J. A. de Lemos
Application of the Screening for Heart Attack Prevention and Education Task Force Recommendations to an Urban Population: Observations From the Dallas Heart Study
Arch Intern Med,
May 26, 2008;
168(10):
1055 - 1062.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Grundy
Metabolic Syndrome Pandemic
Arterioscler Thromb Vasc Biol,
April 1, 2008;
28(4):
629 - 636.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Abbott, H. Ueshima, B. L. Rodriguez, T. Kadowaki, K. H. Masaki, B. J. Willcox, A. Sekikawa, L. H. Kuller, D. Edmundowicz, C. Shin, et al.
Coronary Artery Calcification in Japanese Men in Japan and Hawaii
Am. J. Epidemiol.,
December 1, 2007;
166(11):
1280 - 1287.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Rumberger
The Ethnic Rosetta Stone: Translating Risk Factors, Plaque Scores, and Mortality
J. Am. Coll. Cardiol.,
September 4, 2007;
50(10):
961 - 963.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Zirlik, S. M. Abdullah, N. Gerdes, L. MacFarlane, U. Schonbeck, A. Khera, D. K. McGuire, G. L. Vega, S. Grundy, P. Libby, et al.
Interleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis: Results From the Dallas Heart Study
Arterioscler Thromb Vasc Biol,
September 1, 2007;
27(9):
2043 - 2049.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. See, S. M. Abdullah, D. K. McGuire, A. Khera, M. J. Patel, J. B. Lindsey, S. M. Grundy, and J. A. de Lemos
The Association of Differing Measures of Overweight and Obesity With Prevalent Atherosclerosis: The Dallas Heart Study
J. Am. Coll. Cardiol.,
August 21, 2007;
50(8):
752 - 759.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Wagenknecht, C. D. Langefeld, B. I. Freedman, J. J. Carr, and D. W. Bowden
A Comparison of Risk Factors for Calcified Atherosclerotic Plaque in the Coronary, Carotid, and Abdominal Aortic Arteries: The Diabetes Heart Study
Am. J. Epidemiol.,
August 1, 2007;
166(3):
340 - 347.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. K. Mehta, J. E. Rame, A. Khera, S. A. Murphy, R. M. Canham, R. M. Peshock, J. A. de Lemos, and M. H. Drazner
Left Ventricular Hypertrophy, Subclinical Atherosclerosis, and Inflammation
Hypertension,
June 1, 2007;
49(6):
1385 - 1391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Loria, K. Liu, C. E. Lewis, S. B. Hulley, S. Sidney, P. J. Schreiner, O. D. Williams, D. E. Bild, and R. Detrano
Early Adult Risk Factor Levels and Subsequent Coronary Artery Calcification: The CARDIA Study
J. Am. Coll. Cardiol.,
May 22, 2007;
49(20):
2013 - 2020.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Greenland, R. O. Bonow, B. H. Brundage, M. J. Budoff, M. J. Eisenberg, S. M. Grundy, M. S. Lauer, W. S. Post, P. Raggi, R. F. Redberg, et al.
ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain: A Report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) Developed in Collaboration With the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography
J. Am. Coll. Cardiol.,
January 23, 2007;
49(3):
378 - 402.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Crouse III
Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art
J. Lipid Res.,
August 1, 2006;
47(8):
1677 - 1699.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. J. Kullo, K. Ding, E. Boerwinkle, S. T. Turner, and M. de Andrade
Quantitative trait loci influencing low density lipoprotein particle size in African Americans
J. Lipid Res.,
July 1, 2006;
47(7):
1457 - 1462.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. I. Freedman, D. W. Bowden, M. M. Sale, C. D. Langefeld, and S. S. Rich
Genetic Susceptibility Contributes to Renal and Cardiovascular Complications of Type 2 Diabetes Mellitus
Hypertension,
July 1, 2006;
48(1):
8 - 13.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. W. Wallace, S. M. Abdullah, M. H. Drazner, S. R. Das, A. Khera, D. K. McGuire, F. Wians, M. S. Sabatine, D. A. Morrow, and J. A. de Lemos
Prevalence and Determinants of Troponin T Elevation in the General Population
Circulation,
April 25, 2006;
113(16):
1958 - 1965.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Chung, S. R. Das, D. Leonard, R. M. Peshock, F. Kazi, S. M. Abdullah, R. M. Canham, B. D. Levine, and M. H. Drazner
Women Have Higher Left Ventricular Ejection Fractions Than Men Independent of Differences in Left Ventricular Volume: The Dallas Heart Study
Circulation,
March 28, 2006;
113(12):
1597 - 1604.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. N. Bairey Merz, L. J. Shaw, S. E. Reis, V. Bittner, S. F. Kelsey, M. Olson, B. D. Johnson, C. J. Pepine, S. Mankad, B. L. Sharaf, et al.
Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender Differences in Presentation, Diagnosis, and Outcome With Regard to Gender-Based Pathophysiology of Atherosclerosis and Macrovascular and Microvascular Coronary Disease
J. Am. Coll. Cardiol.,
February 7, 2006;
47(3_Suppl_S):
S21 - S29.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Khera, J. A. de Lemos, R. M. Peshock, H. S. Lo, H. G. Stanek, S. A. Murphy, F. H. Wians Jr, S. M. Grundy, and D. K. McGuire
Relationship Between C-Reactive Protein and Subclinical Atherosclerosis: The Dallas Heart Study
Circulation,
January 3, 2006;
113(1):
38 - 43.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Dries, R. G. Victor, J. E. Rame, R. S. Cooper, X. Wu, X. Zhu, D. Leonard, S.-I. Ho, Q. Wu, W. Post, et al.
Corin Gene Minor Allele Defined by 2 Missense Mutations Is Common in Blacks and Associated With High Blood Pressure and Hypertension
Circulation,
October 18, 2005;
112(16):
2403 - 2410.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. de Lemos, A. Zirlik, U. Schonbeck, N. Varo, S. A. Murphy, A. Khera, D. K. McGuire, G. Stanek, H. S. Lo, R. Nuzzo, et al.
Associations Between Soluble CD40 Ligand, Atherosclerosis Risk Factors, and Subclinical Atherosclerosis: Results from the Dallas Heart Study
Arterioscler Thromb Vasc Biol,
October 1, 2005;
25(10):
2192 - 2196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. V. Diez Roux, R. Detrano, S. Jackson, D. R. Jacobs Jr, P. J. Schreiner, S. Shea, and M. Szklo
Acculturation and Socioeconomic Position as Predictors of Coronary Calcification in a Multiethnic Sample
Circulation,
September 13, 2005;
112(11):
1557 - 1565.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. Drazner, D. L. Dries, R. M. Peshock, R. S. Cooper, C. Klassen, F. Kazi, D. Willett, and R. G. Victor
Left Ventricular Hypertrophy Is More Prevalent in Blacks Than Whites in the General Population: The Dallas Heart Study
Hypertension,
July 1, 2005;
46(1):
124 - 129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Guerra, Z. Yu, S. Marcovina, R. Peshock, J. C. Cohen, and H. H. Hobbs
Lipoprotein(a) and Apolipoprotein(a) Isoforms: No Association With Coronary Artery Calcification in The Dallas Heart Study
Circulation,
March 29, 2005;
111(12):
1471 - 1479.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Bild, R. Detrano, D. Peterson, A. Guerci, K. Liu, E. Shahar, P. Ouyang, S. Jackson, and M. F. Saad
Ethnic Differences in Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA)
Circulation,
March 15, 2005;
111(10):
1313 - 1320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. R. Wilund, L. Yu, F. Xu, G. L. Vega, S. M. Grundy, J. C. Cohen, and H. H. Hobbs
No Association Between Plasma Levels of Plant Sterols and Atherosclerosis in Mice and Men
Arterioscler Thromb Vasc Biol,
December 1, 2004;
24(12):
2326 - 2332.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
Top
Abstract
Methods